NGM·Healthcare·$114M·#133 / 520 in Healthcare
XGN Exagen Inc.
60SOLID
CATEGORY BREAKDOWN
GROWTH31
QUALITY57
STABILITY60
VALUATION97
GOVERNANCE78
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+19.7%
31
> 50% strong
Gross Margin
Revenue retained after direct costs
58.3%
82
> 50% strong
Cash Runway
Months of cash at current burn rate
28 months
90
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
147.3%
1
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.7x
97
< 3x strong
Rule of 40
Growth rate plus operating margin
-1
19
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
27.9%
97
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+9.8%
41
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE XGN WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when XGN's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.